Sotera Health (NASDAQ:SHC) Shares Bought by Tudor Investment Corp ET AL

Tudor Investment Corp ET AL grew its holdings in shares of Sotera Health (NASDAQ:SHC - Free Report) by 14.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 818,691 shares of the company's stock after purchasing an additional 101,272 shares during the period. Tudor Investment Corp ET AL owned about 0.29% of Sotera Health worth $11,200,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Blue Trust Inc. increased its position in shares of Sotera Health by 164.3% in the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company's stock valued at $25,000 after purchasing an additional 1,140 shares during the last quarter. Quarry LP acquired a new position in shares of Sotera Health during the 4th quarter worth about $28,000. GAMMA Investing LLC increased its holdings in shares of Sotera Health by 37.5% in the 4th quarter. GAMMA Investing LLC now owns 4,109 shares of the company's stock valued at $56,000 after acquiring an additional 1,121 shares during the last quarter. Tower Research Capital LLC TRC raised its position in shares of Sotera Health by 37.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company's stock worth $82,000 after acquiring an additional 1,640 shares in the last quarter. Finally, Sterling Capital Management LLC lifted its stake in Sotera Health by 58.5% during the fourth quarter. Sterling Capital Management LLC now owns 9,029 shares of the company's stock worth $124,000 after purchasing an additional 3,331 shares during the last quarter. Institutional investors and hedge funds own 91.03% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the stock. Barclays cut their price objective on shares of Sotera Health from $16.00 to $12.00 and set an "overweight" rating on the stock in a report on Thursday, April 10th. Piper Sandler cut their price target on shares of Sotera Health from $15.00 to $13.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 23rd. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $15.20.

Sotera Health Stock Performance

Shares of SHC traded up $0.28 during mid-day trading on Friday, reaching $12.38. 1,075,697 shares of the company's stock were exchanged, compared to its average volume of 1,204,736. The business's fifty day simple moving average is $11.40 and its 200-day simple moving average is $13.07. The stock has a market capitalization of $3.51 billion, a PE ratio of 49.52 and a beta of 1.88. Sotera Health has a 52-week low of $9.53 and a 52-week high of $17.08. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61.

Sotera Health (NASDAQ:SHC - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The company reported $0.14 EPS for the quarter, beating analysts' consensus estimates of $0.12 by $0.02. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The company had revenue of $254.52 million for the quarter, compared to analyst estimates of $245.56 million. During the same period in the previous year, the business posted $0.13 earnings per share. Sotera Health's quarterly revenue was up 2.6% on a year-over-year basis. On average, equities research analysts expect that Sotera Health will post 0.61 earnings per share for the current year.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.